Sana Biotechnology SANA Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's operating lease liabilities?
- Sana Biotechnology (SANA) reported operating lease liabilities of $60.45M in Q1 2026.
- How has Sana Biotechnology's operating lease liabilities changed year-over-year?
- Sana Biotechnology's operating lease liabilities decreased by 22.8% year-over-year, from $78.31M to $60.45M.
- What is the long-term trend for Sana Biotechnology's operating lease liabilities?
- Over 5 years (2020 to 2025), Sana Biotechnology's operating lease liabilities has grown at a -1.3% compound annual growth rate (CAGR), from $68.2M to $63.92M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.